| 000 | 01179 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514003238.0 | ||
| 264 | 0 | _c20010823 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0277-6715 | ||
| 024 | 7 |
_a10.1002/sim.848 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBabb, J S | |
| 245 | 0 | 0 |
_aPatient specific dosing in a cancer phase I clinical trial. _h[electronic resource] |
| 260 |
_bStatistics in medicine _cJul 2001 |
||
| 300 |
_a2079-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xmethods |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aStatistics as Topic _xmethods |
| 700 | 1 | _aRogatko, A | |
| 773 | 0 |
_tStatistics in medicine _gvol. 20 _gno. 14 _gp. 2079-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/sim.848 _zAvailable from publisher's website |
| 999 |
_c11368351 _d11368351 |
||